Joko K - Search Results

1

Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.

Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, Tada T, Toyoda H, Nouso K, Joko K, Kawasaki H, Hiasa Y, Michitaka K; Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics). Hiraoka A, et al. Among authors: joko k. Liver Cancer. 2017 Jun;6(3):204-215. doi: 10.1159/000452846. Epub 2017 Mar 9. Liver Cancer. 2017. PMID: 28626732 Free PMC article.

2

Characteristics of lamivudine-resistant hepatitis B virus (HBV) strains with and without breakthrough hepatitis in patients with chronic hepatitis B evaluated by serial HBV full-genome sequences.

Horiike N, Duong TN, Michitaka K, Joko K, Hiasa Y, Konishi I, Yano M, Onji M. Horiike N, et al. Among authors: joko k. J Med Virol. 2007 Jul;79(7):911-8. doi: 10.1002/jmv.20915. J Med Virol. 2007. PMID: 17516520

3

Prospective study of chronic hepatitis C treated with reduced initial ribavirin dose.

Konishi I, Hiasa Y, Nonaka T, Hiraoka A, Joko K, Tokumoto Y, Abe M, Matsuura B, Michitaka K, Horiike N, Onji M. Konishi I, et al. Among authors: joko k. Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1227-31. Hepatogastroenterology. 2010. PMID: 21410063

4

Sustained virological response of patients with hepatitis C virus genotype 2 depends on pegylated interferon compliance.

Watanabe T, Konishi I, Shigematsu S, Uesugi K, Joko K, Seike H, Okada S, Miyaoka H, Nakanishi S, Abe M, Matsuura B, Michitaka K, Horiike N, Hiasa Y, Onji M. Watanabe T, et al. Among authors: joko k. Hepatol Res. 2011 Aug;41(8):722-30. doi: 10.1111/j.1872-034X.2011.00816.x. Epub 2011 Jun 17. Hepatol Res. 2011. PMID: 21682826

5

Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.

Takeda H, Nishikawa H, Osaki Y, Tsuchiya K, Joko K, Ogawa C, Taniguchi H, Orito E, Uchida Y, Izumi N; Japanese Red Cross Liver Study Group. Takeda H, et al. Among authors: joko k. Liver Int. 2015 May;35(5):1581-9. doi: 10.1111/liv.12591. Epub 2014 Jun 10. Liver Int. 2015. PMID: 24836552

6

Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan.

Nishikawa H, Takeda H, Tsuchiya K, Joko K, Ogawa C, Taniguchi H, Orito E, Uchida Y, Osaki Y, Izumi N; Japanese Red Cross Liver Study Group. Nishikawa H, et al. Among authors: joko k. J Cancer. 2014 Jun 7;5(7):499-509. doi: 10.7150/jca.9257. eCollection 2014. J Cancer. 2014. PMID: 24963354 Free PMC article.

7

Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group.

Joko K, Goto T, Watanabe H, Mitsuda A, Uchida Y, Hasebe C, Tsuruta S, Kimura H, Koike T, Akamatsu T, Mashiba T, Ochi H, Nakamura Y, Tsuchiya K, Kurosaki M, Izumi N. Joko K, et al. Hepatol Res. 2016 Apr;46(4):251-8. doi: 10.1111/hepr.12515. Epub 2015 Mar 24. Hepatol Res. 2016. PMID: 25753220

8

Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.

Watanabe T, Tokumoto Y, Joko K, Michitaka K, Mashiba T, Hiraoka A, Ochi H, Koizumi Y, Tada F, Hirooka M, Yoshida O, Imai Y, Abe M, Hiasa Y. Watanabe T, et al. Among authors: joko k. Hepatol Int. 2016 Mar;10(2):320-7. doi: 10.1007/s12072-015-9647-8. Epub 2015 Jul 22. Hepatol Int. 2016. PMID: 26198757

9

Simeprevir with peginterferon/ribavirin for patients with hepatitis C virus genotype 1: high frequency of viral relapse in elderly patients.

Watanabe T, Joko K, Seike H, Michitaka K, Horiike N, Kisaka Y, Tanaka Y, Nakanishi S, Nakanishi K, Nonaka T, Yamauchi K, Onji M, Ohno Y, Tokumoto Y, Hirooka M, Abe M, Hiasa Y. Watanabe T, et al. Among authors: joko k. Springerplus. 2016 Apr 26;5:518. doi: 10.1186/s40064-016-2190-9. eCollection 2016. Springerplus. 2016. PMID: 27186482 Free PMC article.

10

Multipolar versus monopolar radiofrequency ablation for hepatocellular carcinoma in the caudate lobe: Results of a propensity score analysis.

Hirooka M, Ochi H, Hiraoka A, Koizumi Y, Tokumoto Y, Abe M, Michitaka K, Joko K, Hiasa Y. Hirooka M, et al. Among authors: joko k. Hepatol Res. 2017 Jun;47(7):658-667. doi: 10.1111/hepr.12791. Epub 2016 Aug 30. Hepatol Res. 2017. PMID: 27509446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters